How it could work

A loop that is not running here.

If design, build, and measurement ever share a labeled contract, later rounds might improve on the same objective. That is a hypothesis. Novel Gene does not operate a foundation model, a wet lab, or an assay panel today.

  1. Design

    Public sequence-design methods exist. Novel Gene does not claim a production model.

  2. Build

    Build capacity would have to be a lab, CRO, or partner. None is selected or claimed.

  3. Measure

    A hit must be defined before any number is published. No Novel Gene assays are claimed.

  4. Learn

    Reusing labels as signal is the untested step. It is not a reported result.

Read the technical hypothesis